Table 1.
Participant characteristics and comparison to excluded cases.
| Total |
Retained |
Excluded |
||
|---|---|---|---|---|
| (n = 39,200) | (n = 14,512) | (n = 24,688) | ES | |
| Age at baseline (M, SD) | 54.82 (7.45) | 53.85 (7.32) | 55.38 (7.48) | g = 0.21 |
| Age at fup 2 (M, SD) | 63.63 (7.54) | 63.50 (7.38) | 63.70 (7.63) | g = 0.03 |
| Sex (% Female) | 52.90% | 51.40% | 53.70% | v <.001 |
| Ethnicity/Race (% White) | 97.00% | 97.30% | 96.80% | v <.01 |
| Townsend score (Mdn, IQR)1 | −2.60 (3.39) | −2.68 (3.30) | −2.56 (3.45) | r = .02 |
| Waist-to-hip at baseline (M, SD) | 0.86 (0.09) | 0.85 (0.08) | 0.86 (0.09) | g = 0.10 |
| BMI at baseline (kg/m2; Mdn, IQR)1 | 25.99 (5.17) | 25.53 (4.76) | 26.29 (5.41) | r = .10 |
| Waist-to-hip at fup 2 (M, SD) | 0.87 (0.09) | 0.87 (0.09) | 0.87 (0.09) | g = 0.002 |
| BMI at fup 2 (kg/m2, Mdn, IQR)1 | 25.87 (5.31) | 25.38 (4.94) | 26.23 (5.55) | r = .11 |
| Avg sleep hours at baseline (Mdn, IQR) 1,a | 7.00 (1.00) | 7.00 (1.00) | 7.00 (1.00) | r = .01 |
| Avg sleep hours at fup 2 (Mdn, IQR) 1,a | 7.00 (1.00) | 7.00 (1.00) | 7.00 (1.00) | r <.001 |
| Alcohol intake day before baseline (Mdn, IQR) 1 | 3.85 (24.00) | 7.05 (24.94) | 0.14 (24.00) | r = −.01 |
| Alcohol intake day before fup 2 (Mdn, IQR) 1 | 7.05 (28.25) | 7.19 (30.29) | 7.05 (27.97) | r <.001 |
| CRP (mg/L; Mdn, IQR) 1 | 1.07 (1.62) | 0.93 (1.31) | 1.18 (1.84) | r = .11 |
| Log CRP (M, SD) | 0.13 (1.02) | −0.04 (0.92) | 0.23 (1.07) | g = 0.27 |
| Any diagnosis (% Yes) b | 23.60% | – | 37.80% | v <.01 |
| Dementia diagnosis (% Yes) | 0.30% | – | 0.40% | v <.01 |
| SSD diagnosis (% Yes) | 0.10% | – | 0.20% | v <.01 |
| Mood disorder diagnosis (% Yes) | 3.50% | – | 5.60% | v <.01 |
| Any medication at baseline (% Yes) c | 21.30% | 15.00% | 24.90% | v <.01 |
| SSRI use at baseline (% Yes) | 2.90% | – | 4.60% | v <.01 |
| Any medication at fup 2 (% Yes) c | 28.70% | 22.50% | 32.30% | v <.01 |
| SSRI use at fup 2 (% Yes) | 3.70% | – | 5.80% | v <.01 |
| IPAQ activity level | v <.01 | |||
| Low | 18.60% | 17.80% | 19.10% | |
| Moderate | 41.90% | 42.80% | 41.20% | |
| High | 39.60% | 39.40% | 39.70% | |
| Current smoker at baseline (% Yes) | 6.30% | 5.50% | 6.70% | v <.01 |
| Current smoker at fup 2 (% Yes) | 4.10% | 2.80% | 4.90% | v <.01 |
| Menopause at baseline d | v <.01 | |||
| Yes | 53.90% | 51.10% | 55.40% | |
| No | 30.90% | 35.70% | 28.20% | |
| Not sure - had a hysterectomy | 10.10% | 7.70% | 11.40% | |
| Not sure - other reason | 5.20% | 5.40% | 5.00% | |
| Menopause at fup 2 d | v <.01 | |||
| Yes | 81.00% | 84.10% | 79.20% | |
| No | 5.40% | 4.70% | 5.80% | |
| Not sure - had a hysterectomy | 9.80% | 7.50% | 11.10% | |
| Not sure - other reason | 3.80% | 3.60% | 3.90% | |
| Dominant hand | v <.01 | |||
| Right | 89.10% | 88.90% | 89.20% | |
| Left | 9.40% | 9.70% | 9.20% | |
| Both | 1.60% | 1.40% | 1.60% |
Note. fup 2 – follow-up 2; BMI – body mass index; CRP – C-reactive protein blood aliquot concentration; SSD – schizophrenia spectrum disorder; SSRI – selective serotonin reuptake inhibitor; IPAQ – International Physical Activity Questionnaire; BMI – body mass index. 1non-normal variable; aAverage hours of sleep per night (self-reported); bAny diagnosis of interest described above; cAny medication of interest described above; dMenopause status applies only to women.